Insider trading

Period: 120 months Stock: VRTX + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

738 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

738 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

738 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

738 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
738 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
738 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

738 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
25 Feb 2021
Parini Michael EVP, Chief Adm, Leg & BD Off
Sold, plan not stated 4×
$646.13K 3,028 at 213.38
8.9%
25 Feb 2021
Silva Paul M SVP & Chief Accounting Officer
Sold, plan not stated 4×
$230.55K 1,080 at 213.47
6.8%
18 Feb 2021
Sachdev Amit EVP, Chief Patient Officer
Sold, plan not stated 4×
$1.96M 9,264 at 211.83
16.6%
18 Feb 2021
ALTSHULER DAVID EVP, Global Research and CSO
Sold, plan not stated 4×
$1.66M 7,825 at 211.83
16.7%
18 Feb 2021
Parini Michael EVP, Chief Adm, Leg & BD Off
Sold, plan not stated 4×
$1.66M 7,825 at 211.83
17.7%
18 Feb 2021
Arbuckle Stuart A EVP, Chief Commercial Officer
Sold, plan not stated 4×
$1.66M 7,825 at 211.82
14.1%
18 Feb 2021
Silva Paul M SVP & Chief Accounting Officer
Sold, plan not stated 3×
$909.83K 4,295 at 211.83
20.3%
11 Feb 2021
ALTSHULER DAVID EVP, Global Research and CSO
Sold, plan not stated 2×
$1.11M 5,283 at 210.54
9.0%
11 Feb 2021
Arbuckle Stuart A EVP, Chief Commercial Officer
Sold, plan not stated 3×
$1.09M 5,156 at 210.55
7.7%
11 Feb 2021
Sachdev Amit EVP, Chief Patient Officer
Sold, plan not stated 3×
$939.07K 4,460 at 210.55
6.6%
11 Feb 2021
Parini Michael EVP, Chief Adm, Leg & BD Off
Sold, plan not stated 3×
$909.18K 4,318 at 210.56
7.9%
11 Feb 2021
Sanna Bastiano EVP, Cell & Genetic Therapies
Sold, plan not stated 2×
$355.01K 1,686 at 210.56
4.2%
11 Feb 2021
Silva Paul M SVP & Chief Accounting Officer
Sold, plan not stated 2×
$315.44K 1,498 at 210.57
5.9%
5 Feb 2021
Parini Michael EVP, Chief Adm, Leg & BD Off
Sold, plan not stated
$414.95K 1,930 at 215.00
3.3%
3 Feb 2021
Arbuckle Stuart A EVP, Chief Commercial Officer
Sold, plan not stated 6×
$332.15K 1,554 at 213.74
2.2%
3 Feb 2021
Parini Michael EVP, Chief Adm, Leg & BD Off
Sold, plan not stated 3×
$86.62K 400 at 216.56
0.7%
16 Nov 2020
Parini Michael EVP, Chief Adm, Leg & BD Off
Sold, plan not stated 3×
$20.34K 91 at 223.53
0.3%
16 Nov 2020
Sachdev Amit EVP, Chief Patient Officer
Sold, plan not stated 3×
$9.39K 42 at 223.53
0.1%
16 Nov 2020
ALTSHULER DAVID EVP, Global Research and CSO
Sold, plan not stated 3×
$8.49K 38 at 223.47
0.1%
16 Nov 2020
Arbuckle Stuart A EVP, Chief Commercial Officer
Sold, plan not stated 2×
$1.57K 7 at 223.64
0.0%
10 Nov 2020
SACHS BRUCE I Director
Bought 3×
$3.26M 15,000 at 217.36
134%
First buy on file
4 Nov 2020
Parini Michael EVP, Chief Adm, Leg & BD Off
Sold, plan not stated 5×
$507.33K 2,330 at 217.74
8.0%
3 Nov 2020
Arbuckle Stuart A EVP, Chief Commercial Officer
Sold, plan not stated 4×
$329.12K 1,553 at 211.92
4.2%
5 Oct 2020
Sold, plan not stated 7×
$2.81M 10,516 at 266.79
72.9%
Sold half or more
6 Aug 2020
Kewalramani Reshma CEO & President
Sold, plan not stated 5×
$562.20K 2,073 at 271.20
7.2%
6 Aug 2020
Parini Michael EVP, Chief Adm, Leg & BD Off
Sold, plan not stated 3×
$331.67K 1,223 at 271.20
4.4%
6 Aug 2020
ALTSHULER DAVID EVP, Global Research and CSO
Sold, plan not stated 3×
$331.66K 1,223 at 271.19
4.1%
6 Aug 2020
Silva Paul M SVP & Controller
Sold, plan not stated 4×
$292.32K 1,078 at 271.17
6.7%
3 Aug 2020
Parini Michael EVP, Chief Adm, Leg & BD Off
Sold, plan not stated 3×
$648.40K 2,330 at 278.28
8.0%
3 Aug 2020
ALTSHULER DAVID EVP, Global Research and CSO
Sold, plan not stated 4×
$648.29K 2,330 at 278.24
7.5%
3 Aug 2020
Sachdev Amit EVP, Chief Patient Officer
Sold, plan not stated 3×
$540.14K 1,941 at 278.28
5.2%
3 Aug 2020
Arbuckle Stuart A EVP, Chief Commercial Officer
Sold, plan not stated 4×
$432.34K 1,553 at 278.39
4.2%
3 Aug 2020
Silva Paul M SVP & Controller
Sold, plan not stated 4×
$225.14K 809 at 278.30
5.1%
13 Jul 2020
Parini Michael EVP, Chief Adm, Leg & BD Off
Sold, plan not stated 9×
$620.61K 2,125 at 292.05
7.3%
13 Jul 2020
Silva Paul M SVP & Controller
Sold, plan not stated 7×
$251.14K 860 at 292.03
5.4%
10 Jul 2020
WAGNER CHARLES F JR EVP & Chief Financial Officer
Sold, plan not stated 3×
$205.21K 700 at 293.15
4.2%
7 Jul 2020
Arbuckle Stuart A EVP, Chief Commercial Officer
Sold, plan not stated
$835.80K 2,786 at 300.00
7.3%
30 Jun 2020
LEIDEN JEFFREY M Executive Chairman
Sold, plan not stated 8×
$9.38M 32,792 at 286.15
93.5%
Sold half or more
2 Jun 2020
Sold, plan not stated 6×
$269.30K 952 at 282.88
14.3%
15 May 2020
Silva Paul M SVP & Controller
Sold, plan not stated 7×
$42.88K 151 at 284.00
1.0%
15 May 2020
Tatsis Ourania EVP, Chief Regulatory Officer
Sold, plan not stated 7×
$34.08K 120 at 284.00
0.9%
15 May 2020
Arbuckle Stuart A EVP, Chief Commercial Officer
Sold, plan not stated 8×
$32.09K 113 at 283.98
0.3%
15 May 2020
Kewalramani Reshma CEO & President
Sold, plan not stated 10×
$28.13K 99 at 284.17
0.4%
15 May 2020
ALTSHULER DAVID EVP, Global Research and CSO
Sold, plan not stated 11×
$23.32K 82 at 284.37
0.3%
15 May 2020
Parini Michael EVP, Chief Adm, Leg & BD Off
Sold, plan not stated 12×
$19.34K 68 at 284.40
0.3%
15 May 2020
Sachdev Amit EVP, Chief Patient Officer
Sold, plan not stated 10×
$16.50K 58 at 284.41
0.2%
12 May 2020
LEIDEN JEFFREY M Executive Chairman
Sold, plan not stated 12×
$26.75M 94,370 at 283.47
73.0%
Sold half or more
12 May 2020
ALTSHULER DAVID EVP, Global Research and CSO
Sold, plan not stated
$374.68K 1,304 at 287.33
4.3%
11 May 2020
Sachdev Amit EVP, Chief Patient Officer
Sold, plan not stated 10×
$3.01M 10,665 at 282.61
23.3%
11 May 2020
Parini Michael EVP, Chief Adm, Leg & BD Off
Sold, plan not stated
$372.94K 1,304 at 286.00
4.6%
Showing 301–350 of 738. ← Newer Page 7 of 15 Older →